Table: Taiko Pharmaceutical - 6-MTH group results
13/08/2026 07:33
Aug 13 (Reuters)-
Taiko Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.64 2.41 7.20
(+9.3 pct) (-15.7 pct) (+12.5 pct)
Operating 17 mln 46 mln 500 mln
(-63.4 pct) (-90.3 pct) (+8.9 pct)
Recurring 41 mln 20 mln 520 mln
(+101.4 pct) (-96.1 pct) (+7.7 pct)
Net 44 mln 279 mln 550 mln
(-84.1 pct) (-63.4 pct) (-40.4 pct)
EPS 0.89 yen 5.57 yen 10.95 yen
Ann Div 3.30 yen 3.50 yen
-Q2 div NIL NIL
-Q4 div 3.30 yen 3.50 yen
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T